Methods of Termination of First-Trimester Miscarriage: Either Medical or Surgical
Methods of Termination of First-Trimester Miscarriage: Either Medical or Surgical
Methods of Termination of First-Trimester Miscarriage: Either Medical or Surgical
Chapter 3:
ovum and 72.0 and 16.1% for missed abortion (P for trend <0.001). Figure
5 displays the proportion of women undergoing surgical treatment within 1 week
according to the type of miscarriage between 1998 and 2016.
24
Review of the literature
25
Review of the literature
History
Over the past three decades, medical methods of abortion have been developed
throughout the world and are now a standard method of providing abortion care
in the United States.
Medical abortion, which involves the use of medications rather than a surgical
procedure to induce an abortion, is an option for women who wish to terminate
the first-trimester pregnancy. Although the method is most commonly used up to
63 days of gestation (calculated from the first day of the last menstrual period), the
treatment also is effective after 63 days of gestation.
The Centers for Disease Control and Prevention estimates that 64% of abortions
are performed before 63 days of gestation (Pazol K, et al 2012).
Medical abortions currently comprise 16.5% of all abortions in the United States
and 25.2% of all abortions at or before 9 weeks of gestation (Pazol K, et al 2012).
PGE2 – an analog that has been connected to coronary spasm and myocardial
infarctions A further step was taken when the anti-progesterone mifepristone
became available for clinical use in the early 1990s (Tang and Ho, 2002, Fiala and Gemzel-
26
Review of the literature
Danielsson, 2006, Bygdeman and Gemzell-Danielsson, 2008). Mifepristone boosts the effect
of PGs in MTOP (Tang and Ho, 2002, Fiala and Gemzel-Danielsson, 2006, Bygdeman and
Gemzell-Danielsson, 2008).
This method of using mifepristone and PGs was developed and first approved for
use during early pregnancy in France in 1988 (Urquhart and Templeton, 1987, Silvestre et
al., 1990, Lalitkumar et al., 2007). A few years later the method was approved for second
trimester TOP (Lalitkumar et al., 2007, Gemzell-Danielsson and Lalitkumar, 2008). However,
it was during 1999–2000 when MTOP with mifepristone and misoprostol was
approved in most European countries (Fiala and Gemzel-Danielsson, 2006, Gemzell-
Danielsson and Lalitkumar, 2008). The Food and Drug Administration approved it in the
US in 2000 and it was approved in Finland in 1999 (Bartz and Goldberg, 2009, Gemzell-
Danielsson and Lalitkumar, 2008).
Prostaglandins (PGs)
Prostaglandins are found in most human tissues and produced by almost all
nucleated cells. They are both autocrine and paracrine lipid mediators that act
upon platelets, endothelium, uterine and mast cells. PGs are synthesized in the cell
from the essential fatty acids (Figure 4) ;(Hammond and O'Donnell, 2012).
27